Atherothrombosis
Information
- Disease name
- Atherothrombosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04677725 | Active, not recruiting | NEtwork to Control ATherothrombosis (NEAT Registry) | September 30, 2020 | April 2023 | |
| NCT01805063 | Completed | Effect of Fire Suppression and Emergency Duties on Vascular Function | January 9, 2012 | December 31, 2016 | |
| NCT01812317 | Completed | N/A | Effect of Real-fire Training on Vascular Function | April 2012 | September 2016 |
| NCT01813032 | Completed | Comparison of Vascular Function in Emergency Service Professionals | April 2012 | April 2013 | |
| NCT01225562 | Completed | Phase 3 | Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin | October 2010 | December 2014 |
| NCT02616497 | Completed | Phase 4 | ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS) | September 2015 | March 28, 2018 |
| NCT01894555 | Completed | Phase 4 | Pharmacogenomics of Antiplatelet Response - II (PARes-II) | January 2013 | August 2014 |
| NCT03943966 | Completed | N/A | In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer | November 11, 2019 | October 13, 2021 |
| NCT03062319 | Recruiting | Phase 4 | Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis | April 6, 2017 | April 30, 2026 |
| NCT01788930 | Terminated | N/A | Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients | February 2013 | October 2017 |
| NCT02898467 | Unknown status | Atherothrombosis Markers in Diabetics | October 2016 | June 2019 |